Arecor Therapeutics confident for the future as revenue rises
(Alliance News) - Arecor Therapeutics PLC on Monday said its revenue increased in 2024 and said it is excited by the prospects of its "superior insulin candidate". The Cambridgeshire, England-based ...
Medindia3d
OnCusp Therapeutics Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer
OnCusp Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer ...
MyChesCo on MSN1d
Windtree Therapeutics Highlights Promising Phase 2b Results for Istaroxime
Windtree Therapeutics, Inc. (NasdaqCM: WINT) showcased encouraging results from the Phase 2b SEISMiC study of istaroxime, its novel investigational therapy for early cardiogenic shock, at the ...
Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data
Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...
Nasdaq15d
Zacks.com featured highlights include OppFi, Corcept Therapeutics, DXP Enterprises, Perpetua Resources and Graham
Corcept Therapeutics Inc. is engaged in the discovery ... The stock price of Perpetua Resources has advanced 6.7% in the past four weeks. It has an expected earnings growth rate of 25.4% for ...
Beating muscle patch keeps heart failure patients alive for years
Patches of beating, lab-grown muscle sewn into failing hearts can keep patients alive for years while they wait for a transplant, scientists have shown. In a major breakthrough, 15 patients suffering ...
Le Lézard10d
Neuboron Medical Group: Pioneering Innovation and Breakthrough in China's BNCT Technology
In recent years, Boron Neutron Capture Therapy (BNCT) has emerged as a cutting-edge cancer treatment technology, experiencing rapid development globally. Neuboron Medical Group (Neuboron), a leading ...
Medindia8d
Global Airway Clearance Devices for Cystic Fibrosis Market to Show Positive Growth at a CAGR of ~5% by 2032 | DelveInsight
DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market analysis, indiv ...
Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
BD Announces Intent To Separate Biosciences And Diagnostic Solutions Business To Enhance Focus, Drive Growth And Unlock Value
Our BD 2025 strategy has transformed the company into a faster-growing, more profitable organization positioned at the forefront of long-term growth ...
Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
PharmiWeb15d
Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Set for Robust Growth Reaching USD 11,698.1 Million by 2034 at a CAGR of 4.4%
Future Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the impressive growth trajectory of the global advanced ...